(Q40910243)

24 September 2017

1 reference

title

The development of a multivalent DNA vaccine for malaria (English)

1 reference

24 September 2017

0 references

1 reference

14

Hoffman SL

1 reference

24 September 2017

Hedstrom RC

1

1 reference

24 September 2017

Doolan DL

2

1 reference

24 September 2017

Wang R

3

1 reference

24 September 2017

Gardner MJ

4

1 reference

24 September 2017

Kumar A

5

1 reference

24 September 2017

Sedegah M

6

1 reference

24 September 2017

Gramzinski RA

7

1 reference

24 September 2017

Sacci JB Jr

8

1 reference

24 September 2017

Charoenvit Y

9

1 reference

24 September 2017

Weiss WR

10

1 reference

24 September 2017

Margalith M

11

1 reference

24 September 2017

Norman JA

12

1 reference

24 September 2017

Hobart P

13

1 reference

24 September 2017

1 January 1997

1 reference

Seminars in Immunopathology

24 September 2017

1 reference

24 September 2017

19

1 reference

24 September 2017

2

1 reference

24 September 2017

147-159

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00870265

24 September 2017

0 references

cites work

Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages.

1 reference

12 December 2020

Structure of Plasmodium falciparum liver stage antigen-1

1 reference

12 December 2020

Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria

1 reference

12 December 2020

Genetic control of immunity to Plasmodium yoelii sporozoites

1 reference

12 December 2020

Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.

1 reference

12 December 2020

Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes

1 reference

12 December 2020

Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge

1 reference

12 December 2020

Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen.

1 reference

12 December 2020

Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2.

1 reference

12 December 2020

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

1 reference

12 December 2020

Immunization against blood-stage rodent malaria using purified parasite antigens.

1 reference

12 December 2020

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein

1 reference

12 December 2020

A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite.

1 reference

12 December 2020

The human tissue plasminogen activator gene.

1 reference

12 December 2020

Recombinant pseudorabies virus carrying a plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity

1 reference

12 December 2020

Experimental challenge of volunteers with malaria.

1 reference

12 December 2020

Common west African HLA antigens are associated with protection from severe malaria

1 reference

12 December 2020

Characterization of Plasmodium falciparum sporozoite surface protein 2

1 reference

12 December 2020

Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes

1 reference

12 December 2020

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

12 December 2020

Evaluation of vaccines designed to induce protective cellular immunity against the Plasmodium yoelii circumsporozoite protein: vaccinia, pseudorabies, and Salmonella transformed with circumsporozoite gene

1 reference

12 December 2020

Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria.

1 reference

12 December 2020

Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody.

1 reference

12 December 2020

Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodium yoelii sporozoite antigen

1 reference

12 December 2020

Merozoite vaccination against Plasmodium knowlesi malaria

1 reference

12 December 2020

Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum.

1 reference

12 December 2020

Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria.

1 reference

12 December 2020

Plasmodium falciparum: exported protein-1, a blood stage antigen, is expressed in liver stage parasites.

1 reference

12 December 2020

Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system

1 reference

12 December 2020

Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination

1 reference

12 December 2020

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

1 reference

12 December 2020

CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites

1 reference

12 December 2020

A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.

1 reference

12 December 2020

Effectiveness of permethrin-impregnated bed nets and curtains for malaria control in a holoendemic area of western Kenya.

1 reference

12 December 2020

A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei

1 reference

12 December 2020

Multi-gene vaccination against malaria: A multistage, multi-immune response approach

1 reference

12 December 2020

Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.

1 reference

12 December 2020

CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria

1 reference

12 December 2020

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.

1 reference

12 December 2020

A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

1 reference

12 December 2020

Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial design

1 reference

12 December 2020

A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 6. The impact of the interventions on mortality and morbidity from malaria

1 reference

12 December 2020

Gamma-globulin and acquired immunity to human malaria.

1 reference

12 December 2020

Immunization against malaria with a recombinant protein.

1 reference

12 December 2020

DNA sequence of the gene encoding a Plasmodium falciparum malaria candidate vaccine antigen.

1 reference

12 December 2020

The major merozoite surface protein as a malaria vaccine target

1 reference

12 December 2020

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

1 reference

12 December 2020

Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages

1 reference

12 December 2020

A malaria sporozoite surface antigen distinct from the circumsporozoite protein

1 reference

12 December 2020

Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccines.

1 reference

12 December 2020

Predicting outcome in malaria: correlation between rate of exposure to infected mosquitoes and level of Plasmodium falciparum parasitemia.

1 reference

12 December 2020

Prospects and strategies for development of DNA vaccines against malaria

1 reference

12 December 2020

A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.

1 reference

12 December 2020

Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens

1 reference

12 December 2020

Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria

1 reference

12 December 2020

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein

1 reference

12 December 2020

Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1.

1 reference

12 December 2020

Irradiated sporozoite vaccine induces cytotoxic T lymphocytes that recognize malaria antigens on the surface of infected hepatocytes

1 reference

12 December 2020

Host age as a determinant of naturally acquired immunity to Plasmodium falciparum

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00870265

1 reference

24 September 2017

1 reference